• Ticker

    Advertisement Find a Broker - Visit the DailyFinance Broker Center
DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

QIAGEN N.V.

NASDAQ:QGEN

$16.52 $0.10 (0.61%)

REAL-TIME: Last trade at

Jump to this page for:

Related Resources

Leerinks' life science tools and medical devices analysts hold a conference call

5/24/2012 by Theflyonthewall.com

Global Laboratory Chemical Reagents Industry

5/16/2012 by PR Newswire

In-Vitro Diagnostics (IVD) Market (Clinical Chemistry, Immunoassays, Molecular Diagnostics, Hematology Analyzers & Microbiology Culture) - Global Trends & Forecasts to 2016

5/9/2012 by PR Newswire

The Zacks Analyst Blog Highlights: Time Warner Cable, Comcast, Verizon Communication, AT&T and Qiagen - Press Releases

5/8/2012 by Zacks Investment Research

Qiagen Expands Its Points of Need - Analyst Blog

5/7/2012 by Zacks Investment Research

Qiagen Expands Its Points of Need

5/7/2012 by Zacks Equity Research Analyst Blog

Qiagen Buys AmniSure for Noninvasive Fetal Membrane Rupture Assay

5/4/2012 by Genetic Engineering News

Qiagen, Sonaecom SGPS SA, Telecom Italia: European Equity Market Preview

5/4/2012 by Bloomberg.com

QIAGEN acquires AmniSure International

5/3/2012 by Theflyonthewall.com

QIAGEN Joins Grand Challenges in Global Health Initiative to Bring Advanced Point-of-Care Diagnostics to World's Poorest Countries

5/3/2012 by Genetic Engineering News

GARP Research Maintains a 'Neutral' on Qiagen NV (QGEN); Q1 Review

5/2/2012 by StreetInsider.com

Qiagen Taps Cardinal Health to Supply Molecular Tests to Small, Mid-Sized Hospitals

5/1/2012 by Genetic Engineering News

QIAGEN, Cardinal Health collaborate to offer molecular diagnostic products

4/30/2012 by Theflyonthewall.com

QIAGEN and Cardinal Health Collaborate to Offer Molecular Diagnostic Products to Smaller and Mid-sized U.S. Hospitals

4/30/2012 by PR Newswire

BioHealth Innovation, Inc. Appoints Qiagen's Douglas Liu to Board of Directors

4/30/2012 by Genetic Engineering News

BioHealth Innovation, Inc. Appoints Qiagen's Douglas Liu to Board of Directors

4/30/2012 by PR Newswire

Qiagen Beats, Reiterates Outllook - Analyst Blog

4/27/2012 by NASDAQ

Qiagen Beats, Reiterates Outllook

4/27/2012 by Zacks Equity Research Analyst Blog

Qiagen Beats, Reiterates Outllook - Analyst Blog

4/27/2012 by Zacks Investment Research

QIAGEN downgraded to Market Perform from Outperform at Leerink

4/27/2012 by Theflyonthewall.com

QIAGEN's CEO Discusses 1Q 2012 Results - Earnings Call Transcript

4/26/2012 by Seeking Alpha

QIAGEN Reports First Quarter 2012 Results

4/25/2012 by Genetic Engineering News

Qiagen NV (QGEN) Tops Q1 EPS by 4c; Guides Q2 Inline

4/25/2012 by StreetInsider.com

QIAGEN sees Q2 EPS around 24c, consensus 24c

4/25/2012 by Theflyonthewall.com

QIAGEN sees FY12 adj EPS $1.03-$1.05, consensus $1.00

4/25/2012 by Theflyonthewall.com

QIAGEN reports Q1 adj EPS 23c, consensus 20c

4/25/2012 by Theflyonthewall.com

QIAGEN Reports First Quarter 2012 Results

4/25/2012 by PR Newswire

FDA Approves Qiagen's IVD Products - Analyst Blog

4/19/2012 by NASDAQ

FDA Approves Qiagen's IVD Products - Analyst Blog

4/19/2012 by Zacks Investment Research

FDA Approves Qiagen's IVD Products

4/19/2012 by Zacks Equity Research Analyst Blog

QIAGEN N.V. to Report First Quarter 2012 Results and Hold Webcast

4/18/2012 by NASDAQ

QIAGEN N.V. to Report First Quarter 2012 Results and Hold Webcast

4/18/2012 by GlobeNewswire

QIAGEN receives FDA clearances for Rotor-Gene Q MDx instrument and compatible Influenza A/B assay; Both products receive 510(k) clearance for in vitro diagnostic use in the U.S.; Rotor-Gene Q MDx platform offers automated real-time PCR testing in molecula

4/17/2012 by Pharmaceutical and Medical Packaging News

QIAGENrReceives FDA clearances for Rotor-Gene Q MDx

4/17/2012 by Theflyonthewall.com

QIAGEN Receives FDA Clearances for Rotor-Gene Q MDx Instrument and Compatible Influenza A/B Assay

4/17/2012 by PR Newswire

Global Gene Amplification Technologies Industry

4/16/2012 by PR Newswire

Penta-His Antibody from Qiagen, used in Western Blotting

4/2/2012 by Biocompare

Qiagen Registers QIAsymphony Sample Prep Module with Chinese SFDA

3/28/2012 by GenomeWeb

QGEN to Gain from Cancer Guideline - Analyst Blog

3/20/2012 by NASDAQ

Leerink's life science tools and diagnostics analyst to hold a conference call

3/20/2012 by Theflyonthewall.com
See More Articles...